It has been reported that AP can alleviate the degree of liver injury induced by D-galactosamine (D-GalN)/lipopolysaccharide (LPS) by increasing the levels of hepatic Nrf-2 and PPAR protein expressions as well as superoxide dismutase, catalase, glutathione s-transferase and glutathione reductase activities and decreasing the levels of hepatic NF-B protein expression and TNF- (Zhou R
Peptides are a string of amino acids, smaller than a protein, that are produced naturally by our body
Rubino reports research grants and consulting fees from Amgen, AstraZeneca, Boehringer Ingelheim, Cytoki Pharma, Eli Lilly, Kallyope, Neurocrine Biosciences, Inc, Nod Thera, Novo Nordisk, Pfizer, Regeneron Pharmaceuticals, Inc, Shionogi, Inc, and Terns Pharmaceuticals
Pedragosa-Badia X, Stichel J, Beck-Sickinger AG